Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women

NCT00442910 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 3% SPL7013 Gel (VivaGel)
DRUG: Placebo Gel
DRUG: HEC Placebo Gel

Sponsor

Starpharma Pty Ltd

Collaborators

[object Object]
[object Object]
[object Object]